SYTL2 antibody
Principal name
SYTL2 antibody
Alternative names for SYTL2 antibody
Synaptotagmin-like protein 2, KIAA1597, SGA72M, SLP2, SLP2A, Breast cancer-associated antigen SGA-72M
Ncbi ID
NM_032943, NM_206929, NM_206930, NP_116561, NP_996812, NP_001156423.1, NP_001035174.1, NM_001040085, NM_031394, NM_001040087, NM_206928, NM_032379, NM_206927, NM_001162952, NM_001162953
Background of SYTL2 antibody
- Kit Component:
- - KN317094G1, Sytl2 gRNA vector 1 in pCas-Guide vector
- KN317094G2, Sytl2 gRNA vector 2 in pCas-Guide vector
- KN317094D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP317584 | SYTL2 (transcript variant a) |
||||
| Recombinant protein of human synaptotagmin-like 2 (SYTL2), transcript variant a | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€788.00
|
|
| OriGene Technologies, Inc. | |||||
| TP317701 | SYTL2 (transcript variant e) |
||||
| Recombinant protein of human synaptotagmin-like 2 (SYTL2), transcript variant e | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY403206 | SYTL2 overexpression lysate |
|
 |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. | ||
| LY404177 | SYTL2 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY404178 | SYTL2 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY430962 | SYTL2 overexpression lysate |
|
|
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. | ||
| LY430963 | SYTL2 overexpression lysate |
|
|
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC217584L2V | Lenti ORF particles, SYTL2 (mGFP-tagged) - Human synaptotagmin-like 2 (SYTL2), transcript variant a, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,020.00
|
|
| OriGene Technologies, Inc. | ||
| RC222514L2V | Lenti ORF particles, SYTL2 (mGFP-tagged)-Human synaptotagmin-like 2 (SYTL2), transcript variant c, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,620.00
|
|
| OriGene Technologies, Inc. | ||
| RC217642L2V | Lenti ORF particles, SYTL2 (mGFP-tagged)-Human synaptotagmin-like 2 (SYTL2), transcript variant d, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,600.00
|
|
| OriGene Technologies, Inc. | ||
| RC222514L1V | Lenti ORF particles, SYTL2 (Myc-DDK-tagged)-Human synaptotagmin-like 2 (SYTL2), transcript variant c, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,370.00
|
|
| OriGene Technologies, Inc. | ||
| RC217642L1V | Lenti ORF particles, SYTL2 (Myc-DDK-tagged)-Human synaptotagmin-like 2 (SYTL2), transcript variant d, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,350.00
|
|
| OriGene Technologies, Inc. | ||